How many insider trades does FilingIQ track for OKUR?

FilingIQ tracks 35 Form 4 insider transactions for OKUR (OnKure Therapeutics, Inc.), covering filings from Oct 4, 2024 onwards. 7 of those were filed in the last 90 days.

Are OKUR insiders net buyers or net sellers?

Across the full Form 4 history for OKUR, 2 transactions (6%) were open-market purchases and 14 (40%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does OKUR insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is OKUR in?

OnKure Therapeutics, Inc. (OKUR) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $54.42M.

OKUR insider trading

NasdaqGM Healthcare

OnKure Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

6% / 40%

Market cap

$54.42M

About OnKure Therapeutics, Inc.

OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Ka) harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company was founded in 2011 and is headquartered in Boulder, Colorado.

Company website: onkuretherapeutics.com

OKUR insider activity at a glance

FilingIQ has scored 35 insider transactions for OKUR since Oct 4, 2024. The most recent filing in our index is dated Apr 1, 2026.

Across the full history, 2 open-market purchases and 14 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on OKUR insider trades is 63.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live OKUR trades on FilingIQ Raw filings on SEC EDGAR

Latest OKUR Form 4 filings

Cormorant Private Healthcare Fund III LP

S May 15, 2025

Leverone Jason A. Chief Financial Officer

S Apr 7, 2025

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for OKUR?: FilingIQ tracks 35 Form 4 insider transactions for OKUR (OnKure Therapeutics, Inc.), covering filings from Oct 4, 2024 onwards. 7 of those were filed in the last 90 days.
Are OKUR insiders net buyers or net sellers?: Across the full Form 4 history for OKUR, 2 transactions (6%) were open-market purchases and 14 (40%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does OKUR insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is OKUR in?: OnKure Therapeutics, Inc. (OKUR) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $54.42M.

Methodology & sources

Every OKUR insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.